Reuters logo
BRIEF-Contravir Pharmaceuticals enters into amended, restated executive agreement with James Sapirstein, CFO
May 26, 2017 / 9:46 PM / 4 months ago

BRIEF-Contravir Pharmaceuticals enters into amended, restated executive agreement with James Sapirstein, CFO

May 26 (Reuters) - Contravir Pharmaceuticals Inc

* On May 25 entered into amended,restated executive agreement with James Sapirstein, chief executive officer - SEC filing

* Pursuant to agreement, Sapirstein’s current base compensation is $480,000 per year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below